PLK1 and cancer: To date, growing evidence indicates that overexpression of Aurora A/B, cyclin D/E, Cdc20, Skp2, and PLK1 has been frequently detected in all kinds of cancers, and these oncoproteins serve as effective therapeutic targets in the clinic (44).